These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

753 related articles for article (PubMed ID: 34120612)

  • 1. Biomimetic black phosphorus quantum dots-based photothermal therapy combined with anti-PD-L1 treatment inhibits recurrence and metastasis in triple-negative breast cancer.
    Zhao P; Xu Y; Ji W; Zhou S; Li L; Qiu L; Qian Z; Wang X; Zhang H
    J Nanobiotechnology; 2021 Jun; 19(1):181. PubMed ID: 34120612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functionalized biomimetic nanoparticles combining programmed death-1/programmed death-ligand 1 blockade with photothermal ablation for enhanced colorectal cancer immunotherapy.
    Xiao Y; Zhu T; Zeng Q; Tan Q; Jiang G; Huang X
    Acta Biomater; 2023 Feb; 157():451-466. PubMed ID: 36442821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Intelligent Biomimetic Nanoplatform for Holistic Treatment of Metastatic Triple-Negative Breast Cancer
    Cheng Y; Chen Q; Guo Z; Li M; Yang X; Wan G; Chen H; Zhang Q; Wang Y
    ACS Nano; 2020 Nov; 14(11):15161-15181. PubMed ID: 33143424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photothermal cancer immunotherapy by erythrocyte membrane-coated black phosphorus formulation.
    Liang X; Ye X; Wang C; Xing C; Miao Q; Xie Z; Chen X; Zhang X; Zhang H; Mei L
    J Control Release; 2019 Feb; 296():150-161. PubMed ID: 30682441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IR792-MCN@ZIF-8-PD-L1 siRNA drug delivery system enhances photothermal immunotherapy for triple-negative breast cancer under near-infrared laser irradiation.
    Wang Y; Wang H; Song Y; Lv M; Mao Y; Song H; Wang Y; Nie G; Liu X; Cui J; Zou X
    J Nanobiotechnology; 2022 Mar; 20(1):96. PubMed ID: 35236356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aptamer targeted therapy potentiates immune checkpoint blockade in triple-negative breast cancer.
    Camorani S; Passariello M; Agnello L; Esposito S; Collina F; Cantile M; Di Bonito M; Ulasov IV; Fedele M; Zannetti A; De Lorenzo C; Cerchia L
    J Exp Clin Cancer Res; 2020 Sep; 39(1):180. PubMed ID: 32892748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Comprehensive Strategy Based on High Clinical Translational Nanosystem for Programmable Immunotherapy of Triple Negative Breast Cancer.
    Meng M; Wu J; Feng Y; Lin L; Chen J; Pang X; Li Y; Hao K; Tian H; Chen X
    Adv Mater; 2024 Jul; 36(27):e2314309. PubMed ID: 38520284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NIR-laser-triggered gadolinium-doped carbon dots for magnetic resonance imaging, drug delivery and combined photothermal chemotherapy for triple negative breast cancer.
    Jiang Q; Liu L; Li Q; Cao Y; Chen D; Du Q; Yang X; Huang D; Pei R; Chen X; Huang G
    J Nanobiotechnology; 2021 Mar; 19(1):64. PubMed ID: 33653352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual-Modality Imaging-Guided Manganese-Based Nanotransformer for Enhanced Gas-Photothermal Therapy Combined Immunotherapeutic Strategy Against Triple-Negative Breast Cancer.
    Guan X; Zeng N; Zhao Y; Huang X; Lai S; Shen G; Zhang W; Wang N; Yao W; Guo Y; Yang R; Wang Z; Jiang X
    Small; 2024 May; 20(22):e2307961. PubMed ID: 38126911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multifunctional Nanoplatform-Mediated Chemo-Photothermal Therapy Combines Immunogenic Cell Death with Checkpoint Blockade to Combat Triple-Negative Breast Cancer and Distant Metastasis.
    Zhu H; Yang K; Yao H; Chen X; Yan S; He Y; Cao Y; Luo J; Wang D
    Int J Nanomedicine; 2023; 18():3109-3124. PubMed ID: 37323948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of triple negative breast cancer by near infrared light triggered mild-temperature photothermal therapy combined with oxygen-independent cytotoxic free radicals.
    Li R; Hu X; Shang F; Wu W; Zhang H; Wang Y; Pan J; Shi S; Dong C
    Acta Biomater; 2022 Aug; 148():218-229. PubMed ID: 35705171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Photothermal Ferrotherapy - Induced Immunogenic Cell Death via Iron-Based Ternary Chalcogenide Nanoparticles Against Triple-Negative Breast Cancer.
    Wu Q; Li Z; Zhou X; Wei Z; Ramadan S; Xu Y; Xu L; Li D
    Small; 2024 May; 20(20):e2306766. PubMed ID: 38095479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Stapled anoplin peptide combined with photothermal therapy enhances oncolytic immunotherapy of triple-negative breast cancer].
    Gao WD; Liu XX; Yang T; Lin JY; Song YX; Lu SX; Zhang XK; Wu Y; Luan X; Zhang WD
    Zhongguo Zhong Yao Za Zhi; 2023 Sep; 48(18):4981-4992. PubMed ID: 37802840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multifunctional Nanoparticles-Mediated PTT/PDT Synergistic Immune Activation and Antitumor Activity Combined with Anti-PD-L1 Immunotherapy for Breast Cancer Treatment.
    Kong C; Xu B; Qiu G; Wei M; Zhang M; Bao S; Tang J; Li L; Liu J
    Int J Nanomedicine; 2022; 17():5391-5411. PubMed ID: 36419717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metal-organic framework-mediated multifunctional nanoparticles for combined chemo-photothermal therapy and enhanced immunotherapy against colorectal cancer.
    Liu H; Xu C; Meng M; Li S; Sheng S; Zhang S; Ni W; Tian H; Wang Q
    Acta Biomater; 2022 May; 144():132-141. PubMed ID: 35307591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "Three-in-one": A Photoactivable Nanoplatform Evokes Anti-Immune Response by Inhibiting BRD4-cMYC-PDL1 Axis to Intensify Photo-Immunotherapy.
    Mohanty A; Lee M; Mohapatra A; Lee H; Vasukutty A; Baek S; Lee JY; Park IK
    Adv Healthc Mater; 2024 Jul; 13(17):e2304093. PubMed ID: 38409920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quercetin-ferrum nanoparticles enhance photothermal therapy by modulating the tumor immunosuppressive microenvironment.
    Li L; Zhang M; Liu T; Li J; Sun S; Chen J; Liu Z; Zhang Z; Zhang L
    Acta Biomater; 2022 Dec; 154():454-466. PubMed ID: 36243377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synchronous targeted delivery of TGF-β siRNA to stromal and tumor cells elicits robust antitumor immunity against triple-negative breast cancer by comprehensively remodeling the tumor microenvironment.
    Yang M; Qin C; Tao L; Cheng G; Li J; Lv F; Yang N; Xing Z; Chu X; Han X; Huo M; Yin L
    Biomaterials; 2023 Oct; 301():122253. PubMed ID: 37536040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PD-L1 blockade TAM-dependently potentiates mild photothermal therapy against triple-negative breast cancer.
    Wang C; Xu YH; Xu HZ; Li K; Zhang Q; Shi L; Zhao L; Chen X
    J Nanobiotechnology; 2023 Dec; 21(1):476. PubMed ID: 38082443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of Chidamide-Mediated Epigenetic Modulation with Immunotherapy: Boosting Tumor Immunogenicity and Response to PD-1/PD-L1 Blockade.
    Tu K; Yu Y; Wang Y; Yang T; Hu Q; Qin X; Tu J; Yang C; Kong L; Zhang Z
    ACS Appl Mater Interfaces; 2021 Aug; 13(33):39003-39017. PubMed ID: 34433253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.